| Product Code: ETC13228088 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Radiopharmaceuticals & Contrast Media Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Radiopharmaceuticals & Contrast Media Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Radiopharmaceuticals & Contrast Media Market - Industry Life Cycle |
3.4 Africa Radiopharmaceuticals & Contrast Media Market - Porter's Five Forces |
3.5 Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Type of Imaging Modality, 2021 & 2031F |
3.7 Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By PET, 2021 & 2031F |
3.8 Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Diagnostic SPECT Application, 2021 & 2031F |
3.9 Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By PET Applications, 2021 & 2031F |
3.10 Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
3.11 Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Contrast Media Type, 2021 & 2031F |
3.12 Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.12 Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Africa Radiopharmaceuticals & Contrast Media Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Radiopharmaceuticals & Contrast Media Market Trends |
6 Africa Radiopharmaceuticals & Contrast Media Market, 2021 - 2031 |
6.1 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Tc-99, 2021 - 2031 |
6.1.3 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Tl-201, 2021 - 2031 |
6.1.4 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Ga-67, 2021 - 2031 |
6.1.5 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By I-123, 2021 - 2031 |
6.1.6 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other SPECTs, 2021 - 2031 |
6.2 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By F-18, 2021 - 2031 |
6.2.3 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Rb-82, 2021 - 2031 |
6.2.4 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other PETs, 2021 - 2031 |
6.3 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Cardiology, 2021 - 2031 |
6.3.3 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.3.4 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Thyroid, 2021 - 2031 |
6.3.5 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other SPECT Applications, 2021 - 2031 |
6.4 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.4.3 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Cardology, 2021 - 2031 |
6.4.4 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.4.5 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other PET Applications, 2021 - 2031 |
6.5 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Thyroid, 2021 - 2031 |
6.5.3 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Lymphoma, 2021 - 2031 |
6.5.4 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Endocrine Tumors, 2021 - 2031 |
6.5.5 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other Therapeutic Applications, 2021 - 2031 |
6.6 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Iodinated Contrast Media, 2021 - 2031 |
6.6.3 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Gadolinium-based Contrast Media, 2021 - 2031 |
6.6.4 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Microbubble Contrast Media, 2021 - 2031 |
6.6.5 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Barium-based Contrast Media, 2021 - 2031 |
6.7 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By X-ray/Computed Tomography (CT), 2021 - 2031 |
6.7.3 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Magnetic Resnance Imaging (MRI), 2021 - 2031 |
6.7.4 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Ultrasound, 2021 - 2031 |
6.8 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
6.8.1 Overview & Analysis |
6.8.2 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Cardiovascular Disease, 2021 - 2031 |
6.8.3 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.8.4 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Gastrointestinal Disorders, 2021 - 2031 |
6.8.5 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Neurological Disorders, 2021 - 2031 |
6.8.6 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other Indications, 2021 - 2031 |
7 Africa Radiopharmaceuticals & Contrast Media Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.1 South Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.2 Egypt Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.3 Nigeria Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.4 Rest of Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.3 Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By PET, 2021 & 2031F |
7.3.1 South Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.3.2 Egypt Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.3.3 Nigeria Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.3.4 Rest of Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.4 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.1 South Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.2 Egypt Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.3 Nigeria Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.4 Rest of Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.5 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.1 South Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.2 Egypt Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.3 Nigeria Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.4 Rest of Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.6 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.1 South Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.2 Egypt Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.3 Nigeria Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.4 Rest of Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.7 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.1 South Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.2 Egypt Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.3 Nigeria Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.4 Rest of Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.8 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.1 South Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.2 Egypt Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.3 Nigeria Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.4 Rest of Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.9 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.1 South Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.2 Egypt Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.3 Nigeria Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.4 Rest of Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Africa Radiopharmaceuticals & Contrast Media Market Key Performance Indicators |
9 Africa Radiopharmaceuticals & Contrast Media Market - Export/Import By Countries Assessment |
10 Africa Radiopharmaceuticals & Contrast Media Market - Opportunity Assessment |
10.1 Africa Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Type of Imaging Modality, 2021 & 2031F |
10.3 Africa Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By PET, 2021 & 2031F |
10.4 Africa Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Diagnostic SPECT Application, 2021 & 2031F |
10.5 Africa Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By PET Applications, 2021 & 2031F |
10.6 Africa Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
10.7 Africa Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Contrast Media Type, 2021 & 2031F |
10.8 Africa Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Procedure, 2021 & 2031F |
10.9 Africa Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Application, 2021 & 2031F |
11 Africa Radiopharmaceuticals & Contrast Media Market - Competitive Landscape |
11.1 Africa Radiopharmaceuticals & Contrast Media Market Revenue Share, By Companies, 2022 |
11.2 Africa Radiopharmaceuticals & Contrast Media Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here